Approval · Notice of Compliance 7446 · 2005
RATIO-SUMATRIPTAN: Notice of Compliance 7446
Issued September 26, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7446
- Date
- September 26, 2005
- Company
- Ratiopharm Inc.Ulm, --, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- 5-ht1 receptor agonist, migraine therapy
- Canadian reference product
- IMITREX (Glaxosmithkline Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RATIO-SUMATRIPTAN | 02271575 | — |
| RATIO-SUMATRIPTAN | 02271583 | Cancelled Post Market |
| RATIO-SUMATRIPTAN | 02271591 | Cancelled Post Market |
Medicinal ingredients
- SUMATRIPTAN SUCCINATE 25 MG per TAB
- SUMATRIPTAN SUCCINATE 50 MG per TAB
- SUMATRIPTAN SUCCINATE 100 MG per TAB